Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Trane Technologies plc (TT) Price & Performance

Kymera Therapeutics Inc. Common StockTrade
Trane Technologies plcTrade

Price performance (Past 24H)

Key statistics

Kymera Therapeutics Inc. Common Stock vs Trane Technologies plc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Trane Technologies plc trades at $471.84 (market cap $105.17B). The key difference: Trane Technologies plc is far larger — about 11.9× Kymera Therapeutics Inc. Common Stock's market cap, and Trane Technologies plc pays a 0.88% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.

KYMRTT
Market Cap
$8.87B$105.17B
Volume
779,1071,040,183
Sector
HealthIndustrials
52-Week High
$127.31$503.46
52-Week Low
$55.80$376.43
Typical Hold Time
0 Days—
Enterprise Value
$8.26B$108.47B
Dividend Yield
—0.88%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KYMR
100% Buy0% Sell
Avg holding period · 0 Days
TT

No sentiment data available yet.

Top news

Latest headlines on both assets

About Kymera Therapeutics Inc. Common Stock

Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.

Read more on KYMR →

About Trane Technologies plc

Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.

Read more on TT →